181 related articles for article (PubMed ID: 12720105)
1. Active chemotherapy for bone metastasis in sarcomatoid renal cell carcinoma.
Hoshi S; Satoh M; Ohyama C; Hiramatu M; Watanabe R; Hagisawa S; Endo M; Arai Y
Int J Clin Oncol; 2003 Apr; 8(2):113-7. PubMed ID: 12720105
[TBL] [Abstract][Full Text] [Related]
2. Active chemotherapy for collecting duct carcinoma of the kidney: a case report and review of the literature.
Milowsky MI; Rosmarin A; Tickoo SK; Papanicolaou N; Nanus DM
Cancer; 2002 Jan; 94(1):111-6. PubMed ID: 11815966
[TBL] [Abstract][Full Text] [Related]
3. Weekly administration of gemcitabine plus docetaxel in patients with advanced breast cancer: a phase 1 study.
Brugnatelli S; Danova M; De Bella MT; Vaglica M; Manuguerra G; Riccardi A; Palmeri S
Oncology; 2002; 62(1):33-8. PubMed ID: 11810041
[TBL] [Abstract][Full Text] [Related]
4. [Active chemotherapy with gemcitabine, carboplatin and docetaxel for three patients with MVAC-resistant liver metastasis of urothelial carcinoma].
Inoue T; Ohyama C; Horikawa Y; Togashi H; Matsuura S; Tsuchiya N; Satoh S; Sato K; Habuchi T; Saito S; Hoshi S; Arai Y; Kato T
Hinyokika Kiyo; 2004 Apr; 50(4):273-7. PubMed ID: 15188623
[TBL] [Abstract][Full Text] [Related]
5. Gemcitabine and docetaxel as second-line chemotherapy for patients with nonsmall cell lung carcinoma who fail prior paclitaxel plus platinum-based regimens.
Kosmas C; Tsavaris N; Vadiaka M; Stavroyianni N; Koutras A; Malamos N; Onyenadum A; Rokana S; Polyzos A; Kalofonos HP
Cancer; 2001 Dec; 92(11):2902-10. PubMed ID: 11753965
[TBL] [Abstract][Full Text] [Related]
6. Recurrent ovarian cancer metastatic to the sternum, costae, and thoracic wall after prolonged treatment with platinum-based chemotherapy: a case report and review of the literature.
Pavlakis G; Mountzios G; Terpos E; Leivaditou A; Papadopoulos G; Papasavas P
Int J Gynecol Cancer; 2006; 16 Suppl 1():299-303. PubMed ID: 16515608
[TBL] [Abstract][Full Text] [Related]
7. Phase I trial of docetaxel, carboplatin, and gemcitabine as first-line therapy for patients with high-risk epithelial tumors of müllerian origin.
Berkenblit A; Tung N; Kim Y; Feyler H; Niloff J; Berghe KV; Cannistra SA
Gynecol Oncol; 2003 Jun; 89(3):486-93. PubMed ID: 12798716
[TBL] [Abstract][Full Text] [Related]
8. [An autopsy case of pulmonary and central nervous system metastatic osteosarcoma treated with thirty-six courses of chemotherapy over four years].
Ito T; Mochida A; Saito K; Nishi K; Sasaki S; Hisada T; Morinari H; Nakahara K; Tahara M; Masuda S; Yakumaru K
Nihon Kokyuki Gakkai Zasshi; 2002 Jan; 40(1):71-6. PubMed ID: 11925923
[TBL] [Abstract][Full Text] [Related]
9. Combination chemotherapy with carboplatin, docetaxel, and gemcitabine in advanced non-small-cell lung cancer: a phase II study.
Pectasides D; Aspropotamitis A; Halikia A; Visvikis A; Antoniou F; Kalantaridou A; Karvounis N; Batzios S; Athanassiou A
J Clin Oncol; 1999 Dec; 17(12):3816-21. PubMed ID: 10577854
[TBL] [Abstract][Full Text] [Related]
10. Dose-finding, pharmacokinetic and phase II study of docetaxel in combination with gemcitabine in patients with inoperable non-small cell lung cancer.
Rebattu P; Quantin X; Ardiet C; Morere JF; Azarian MR; Schuller-Lebeau MP; Pujol JL
Lung Cancer; 2001; 33(2-3):277-87. PubMed ID: 11551423
[TBL] [Abstract][Full Text] [Related]
11. Comparative effectiveness of three platinum-doublet chemotherapy regimens in elderly patients with advanced non-small cell lung cancer.
Zhu J; Sharma DB; Chen AB; Johnson BE; Weeks JC; Schrag D
Cancer; 2013 Jun; 119(11):2048-60. PubMed ID: 23564469
[TBL] [Abstract][Full Text] [Related]
12. Sarcomatoid renal cell carcinoma: biologic behavior, prognosis, and response to combined surgical resection and immunotherapy.
Cangiano T; Liao J; Naitoh J; Dorey F; Figlin R; Belldegrun A
J Clin Oncol; 1999 Feb; 17(2):523-8. PubMed ID: 10080595
[TBL] [Abstract][Full Text] [Related]
13. [A case of left urothelial carcinoma with multiple bone metastasis, liver metastasis and right adrenal metastasis successfully treated with combination chemotherapy of gemcitabine and carboplatin].
Nakagawa T; Kiba T; Mori M; Hokkoku K; Watanabe Y; Oikawa M; Shintaku K; Mizuno T; Yoshimitsu Y; Sakuma H; Ueda H; Nakai M
Gan To Kagaku Ryoho; 2008 Aug; 35(8):1419-21. PubMed ID: 18701863
[TBL] [Abstract][Full Text] [Related]
14. Major response and clinical benefit following third-line treatment for Bellini duct carcinoma.
Fakhrai N; Haitel A; Balassy C; Zielinski CC; Schmidinger M
Wien Klin Wochenschr; 2005 Jan; 117(1-2):63-5. PubMed ID: 15986594
[TBL] [Abstract][Full Text] [Related]
15. [Carboplatin].
Watanabe H
Nihon Rinsho; 2002 May; 60 Suppl 5():366-9. PubMed ID: 12101690
[No Abstract] [Full Text] [Related]
16. Platinum-based and non-platinum-based chemotherapy in advanced non-small-cell lung cancer: a randomised multicentre trial.
Georgoulias V; Papadakis E; Alexopoulos A; Tsiafaki X; Rapti A; Veslemes M; Palamidas P; Vlachonikolis I;
Lancet; 2001 May; 357(9267):1478-84. PubMed ID: 11377599
[TBL] [Abstract][Full Text] [Related]
17. Phase II study of first-line sequential chemotherapy with gemcitabine-carboplatin followed by docetaxel in patients with advanced non-small cell lung cancer.
Chiappori A; Simon G; Williams C; Haura E; Rocha-Lima C; Wagner H; Bepler G; Antonia S
Oncology; 2005; 68(4-6):382-90. PubMed ID: 16020967
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathologic characteristics and prognostic factors of sarcomatoid renal cell carcinoma.
Yan Y; Liu L; Zhou J; Li L; Li Y; Chen M; Wang L; He W; Guan X; Zu X; Qi L
J Cancer Res Clin Oncol; 2015 Feb; 141(2):345-52. PubMed ID: 25178995
[TBL] [Abstract][Full Text] [Related]
19. Randomized phase II trial of sequential chemotherapy in advanced non-small cell lung cancer (SWOG 9806): carboplatin/gemcitabine followed by paclitaxel or cisplatin/vinorelbine followed by docetaxel.
Edelman MJ; Clark JI; Chansky K; Albain K; Bhoopalam N; Weiss GR; Giguere JK; Kelly K; Crowley J; Gandara DR
Clin Cancer Res; 2004 Aug; 10(15):5022-6. PubMed ID: 15297403
[TBL] [Abstract][Full Text] [Related]
20. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.
Clegg A; Scott DA; Sidhu M; Hewitson P; Waugh N
Health Technol Assess; 2001; 5(32):1-195. PubMed ID: 12065068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
